The coordinated buying by multiple fund types, especially Elliott's activist push, suggests a re-rating catalyst may be approaching. Watch for upcoming earnings, FDA updates on DefenCath, or potential strategic moves. The 45-day filing lag means positions may have been adjusted since December; any 13D amendment filing by Elliott would be an immediate bullish trigger.
Executive Summary
A strong institutional cluster formed in CRMD during Q4 2024, with 8 buyers (net +$14.6M) overwhelming 3 sellers (net -$5.8M). The accumulation is led by activist Elliott Management, which added 85% to now hold $23.3M, alongside participation from quant fund D.E. Shaw and mega-passive UBS. This signals growing conviction in CorMedix's commercial prospects ahead of potential catalysts.
Key Financial Metrics
Institutional Positions
Net institutional flow: $8.8M
▲ Buyers (8)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Elliott Management | ADD | +85.1% | $23.3M | $10.7M |
| D.E. Shaw | ADD | +39.1% | $3.6M | $1.0M |
| UBS | DOUBLED | +861.3% | $3.1M | $2.8M |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Voya Investment Management | NEAR_EXIT | -97.5% | $5.8M | -$5.6M |
Key Facts
- 8 institutional buyers vs 3 sellers in Q4 2024
- Elliott Management (activist) increased stake by 85.1% to 2.87M shares ($23.3M)
- UBS more than doubled its position (+861%), now holding $3.1M
- D.E. Shaw added 39.1%, now $3.6M
- Net institutional inflow of approximately $8.8M
- Voya Investment Management nearly exited (-97.5%), selling $5.6M
Financial Impact
Net institutional buying of $8.8M in Q4 2024, with $14.6M added by buyers and $5.8M sold by sellers. The cluster represents new capital deployment into CRMD at a time of high analyst bullishness (92% buy ratings).
Risk Factors
- 13F data is 45+ days stale; positions may have been partially unwound
- Small-cap biotech volatility could reverse gains quickly
- Voya's near-exit signals some institutional skepticism
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CRMD-2024-Q4 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 7w ago | 8-K | $8.14 $7.83 | ▼ −3.87% | ▼ −2.12% | — |
Aug 13, 2026 7w ago | Press Release | $8.14 $7.83 | ▼ −3.87% | ▼ −2.12% | — |
Jul 1, 2026 13w ago | 8-K | $8.47 $7.19 | ▼ −15.11% | ▼ −12.93% | — |
Jun 12, 2026 16w ago | Institutional Cluster | $8.74 $8.40 | ▼ −3.89% | ▼ −5.67% | — |
Jun 8, 2026 16w ago | 8-K | $8.54 $8.79 | ▲ +2.93% | ▲ +1.30% | — |
Jun 8, 2026 16w ago | Press Release | $8.54 $8.79 | ▲ +2.93% | ▲ +1.30% | — |
May 14, 2026 20w ago | 8-K | $7.93 $8.74 | ▲ +10.21% | ▲ +11.07% | — |
May 14, 2026 20w ago | Press Release | $7.93 $8.74 | ▲ +10.21% | ▲ +11.07% | — |
Apr 27, 2026 22w ago | 8-K | $7.82 $8.27 | ▲ +5.75% | ▲ +0.80% | — |
Apr 27, 2026 22w ago | Press Release | $7.82 $8.27 | ▲ +5.75% | ▲ +0.80% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access